Filing Flows › Zimmer Biomet Holdings (ZBH) › R&D spending
Zimmer Biomet Holdings (ZBH) R&D spending by quarter
Zimmer Biomet Holdings' R&D spending was $106M in Q3 2026 (third quarter 2026), +1% from Q2 2026. Over the last 7 quarters it ranged from $103M (Q1 2026) to $119M (Q4 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $106M | +1% | -9% |
| Q2 2026 | $105M | +1% | -8% |
| Q1 2026 | $103M | -13% | -7% |
| Q4 2025 | $119M | +2% | — |
| Q3 2025 | $116M | +2% | — |
| Q2 2025 | $113M | +2% | — |
| Q1 2025 | $111M | — | — |
Q3 2026 at a glance
Zimmer Biomet Holdings, Q3 2026: revenue $2.1B (+3% year over year), operating margin 14.9%, net earnings $193M, operating cash flow $560M. The chart follows the revenue to costs, profit and cash.
Questions
What is Zimmer Biomet Holdings' R&D spending?
Zimmer Biomet Holdings' R&D spending was $106M in Q3 2026 (third quarter 2026), +1% from Q2 2026.
How has Zimmer Biomet Holdings' R&D spending changed?
Over the last 7 quarters it ranged from $103M (Q1 2026) to $119M (Q4 2025).
Q3 2026 results → · How Zimmer Biomet Holdings makes money →